At 14.3% CAGR, the North America Breath Analyzer Market is Projected to be Worth US$ 1,497.21 Million by 2030, says Business Market Insights

According to Business Market Insights research, the North America breath analyzer market was valued at US$ 514.14 million in 2022 and is expected to reach US$ 1,497.21 million by 2030, registering a CAGR of 14.3% from 2022 to 2030. Growing alcohol consumption and alcohol-impaired accidents as well as government support and advanced technologies implementation for breath analyzers are the critical factors attributed to the North America breath analyzer market expansion.

According to the World Data report published in 2022, the average consumption of alcohol across the world is 6.182 liters per person. The World Health Organization (WHO) reveals that excessive alcohol consumption results in 3 million deaths every year (representing 5.3% of the overall deaths worldwide), causing harm to the well-being and health of people. Additionally, 5.1% of the global burden of disease and injury caused to an individual due to alcohol drunken driving causes social and economic losses to individuals and society. Excessive alcohol consumption results in road traffic crashes and accidents. The US Department of Health & Human Services report reveals 11,654 deaths due to motor vehicle crashes caused by alcohol-impaired drivers, accounting for 30% of all traffic-related deaths in the US in 2020. There was a 14.3% rise in 2020 compared to alcohol-impaired deaths in 2019. Also, the annual estimated healthcare cost of treatments and deaths due to accidents caused by alcohol-impaired drivers was US$ 123.3 billion in 2020. The National Transportation Safety Board (NTSB) announced the installation of in-vehicle alcohol detection technology, lowering the blood alcohol concentration limit to 0.05 g/dl or lower, to prevent alcohol and other drug-impaired driving crashes after an incident happened in California that killed nine people, including seven children. Therefore, the rising number of deaths due to accidents caused by drunken driving accelerates demand for breath analyzers.

On the contrary, false results by breath analyzers hampers the North America breath analyzer market.

Based on technology, the North America breath analyzer market is segmented into fuel cell technology, infrared spectroscopy, semiconductor sensor, and others. The fuel cell technology segment held 57.5% share of North America breath analyzer market in 2022, amassing US$ 295.84 million. It is projected to garner US$ 910.76 million by 2030 to expand at 15.1% CAGR during 2022-2030.

In terms of application, the North America breath analyzer market is categorized into alcohol detection, medical applications, and drug abuse detection. The medical applications segment held 50.4% share of North America breath analyzer market in 2022, amassing US$ 259.33 million. It is projected to garner US$ 802.93 million by 2030 to expand at 15.2% CAGR during 2022-2030.

Based on end user, the North America breath analyzer market is categorized into hospitals and diagnostic centers, law enforcement agencies, and others. The hospitals and diagnostic centers segment held 46.5% share of North America breath analyzer market in 2022, amassing US$ 238.90 million. It is projected to garner US$ 680.45 million by 2030 to expand at 14.0% CAGR during 2022-2030.

By country, the North America breath analyzer market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 85.5% share of North America breath analyzer market in 2022. It was assessed at US$ 439.49 million in 2022 and is likely to hit US$ 1,309.76 million by 2030, exhibiting a CAGR of 14.6% during 2022-2030.

Key players operating in the North America breath analyzer market are Thermo Fisher Scientific Inc, Lifeloc Technologies Inc, Dragerwerk AG & Co KGaA, Abbott Laboratories, Honeywell International Inc, KHN Solutions LLC, Bedfont Scientific Ltd, and Intoximeters Inc, among others.

• In August-2019, Abbott and Intoximeters entered into an agreement for Intoximeters to market Abbott's SoToxaTM Mobile Test System, a handheld oral fluid roadside testing solution that rapidly and reliably detects recent drug use with Intoximeters' Alco-Sensor brand breath alcohol-testing products. This agreement aided law enforcement agencies in their efforts to reduce the rate of drugged driving, which has become a serious road safety issue.
  
  
  Contact Us
  Phone: +16467917070
  Email Id: sales@businessmarketinsights.com